Manufacturer record
Paschim Banga Pharmaceuticals NH-31: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Paschim Banga Pharmaceuticals NH-31 were declared Not of Standard Quality between April 2020 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 03B3911, Compound Sodium Lactate Injection I.P. (exp May 2026). RDTL, Guwahati (CDSCO lab) found it not of standard quality: The sample does not comply as per I.P. 2022 with respect to the test for "Sterility". Listed in the November 2025 alert.
Records by type
2 records linked to Paschim Banga Pharmaceuticals NH-31 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Compound Sodium Lactate Injection I.P. | Batch 03B3911Mfg Jun 2023 · Exp May 2026 | The sample does not comply as per I.P. 2022 with respect to the test for "Sterility".Sterility | RDTL, GuwahatiCDSCO lab | Nov 2025 |
| Compound Sodium Lactate Injections 500ml (RL) | Batch 03BF0799Mfg Jan 2019 · Exp Dec 2021 | BETOther | RDTL GuwahatiState lab | Apr 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.